Thursday, November 17, 2005 10:59:53 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 12b-25
NOTIFICATION OF LATE FILING
___Form 10-K ___Form 20-F ___Form 11-K X Form 10-Q ___ Form N-SAR
-----
For the Period Ended September 30, 2005
Commission file number 0-28498
----------
Paradigm Medical Industries, Inc.
---------------------------------
Full Name of Registrant
2355 South 1070 West
------------------------------------------
Address of Principle Executive Offices (street and number)
Salt Lake City, Utah 84119
--------------------------
City, State and Zip Code
Part II - Rules 12b-25 (b) and (c)
If the subject could be filed without unreasonable effort or expense
and the Registrant seeks relief pursuant to Rule 12b-25 (b), the following
should be completed. (Check if appropriate).
X (a) The reasons described in reasonable detail in Part III of
------ this form could not be eliminated without unreasonable
effort of expense;
X (b) The subject annual report, semi-annual report, transition
------ report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or
portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q,
or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
------ (c) The accountant's statements or other exhibit required by
Rule 12b-25 (c) has been attached if applicable.
<Page>
Part III - Narrative
State below in reasonable detail the reasons why Form 10-K, 10-KSB,
20-F, 11-K, 10-Q, 10-QSB, N-SAR, or the transition report or portion
thereof, could not be filed within the prescribed time period.
The quarterly report of the registrant on Form 10-QSB could not be
filed because management requires additional time to compile and
verify the data required to be included in the report. The report
will be filed within five days of the date the original report was
due.
Part IV - Other Information
Name and telephone number of person to contact in regard to this
notification
John Yoon (801) 924-8872
----------------- --------- ----------------
Name Area Code Telephone Number
Have all other reports required under Section 13 or 15 (b) of the
Securities and Exchange Act of 1934 or Section 30 or the Investments
Act of 1940 during the preceding 12 months (or for such shorter)
period that the Registrant was required to file such reports been
filed? If answer is no, identify report(s).
X Yes No
------ -----
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
Yes X No
------ -----
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
Paradigm Medical Industries, Inc.
---------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: November 14, 2005 By: /S/ John Yoon
---------------------------------------
John Yoon, President
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM